Mechanistically, TRIM28 interacts with CARM1 (Co-activator-associated arginine methyltransferase1) and protects CARM1 from degradation, thereby inhibiting WNT/β-catenin signaling to inhibit the migration and invasion of CRC cells (Cui et al., 2019). This evidence concerns the gene CARM1 and colorectal carcinoma.